SARS-achtig virus duikt op MERS (Middle East respiratory syndrome- coronavirus)

Auteur Topic: SARS-achtig virus duikt op MERS (Middle East respiratory syndrome- coronavirus)  (gelezen 72632 keer)

0 gebruikers (en 2 gasten bekijken dit topic.

RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
Citaat
Een nieuw coronavirus is opgedoken in het Midden-Oosten. Virologen uit Rotterdam analyseren het SARS-achtige virus. Gezondheidsautoriteiten in het Midden-Oosten staan niet te springen om meer onderzoek naar het virus te doen.

http://medischcontact.artsennet.nl/nieuws-26/nieuwsbericht/129531/sarsachtig-virus-verder-ontrafeld.htm


Zie voor uitbraak SARS dit topic:
http://www.hulpverleningsforum.nl/index.php?topic=716.0




RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
Citaat
Tweede geval SARS-achtig virus in Frankrijk
In Frankrijk is voor de tweede keer bij een patiënt de gevaarlijke nieuwe variant op het SARS–virus geconstateerd. De patiënt lag in een ziekenhuis in het Noord–Franse Lille op dezelfde zaal als de eerste patiënt die in Frankrijk het virus bleek te hebben, meldden Franse media zondag. De Wereldgezondheidsorganisatie zegt ondertussen aanwijzingen te hebben dat het virus ook van mens op mens kan overgaan. lees verder
bron: Reformatorisch Dagblad


RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
WHO @WHO

Novel coronavirus is a new infection and there are also many gaps in our knowledge that will inevitably take time to fill in. #nCoV
Novel coronavirus is caused by a virus from coronaviruses group. Another from the group is SARS, however #nCoV is NOT SARS
Novel coronavirus: We don’t know where this virus lives. We don’t know how often people might develop mild disease. We aren't sure why #nCoV
The greatest global concern of novel coronavirus, however, is about the potential for this new virus to spread #nCoV
3:30pm · 12 May 13

Novel coronavirus clusters seen in countries increasingly support the hypothesis that the virus can transmit H2H with close contacts #nCoV
Novel coronavirus person-to-person transmission has remained limited to some small clusters so far #nCoV
Novel coronavirus: Countries need to increase surveillance, as well as awareness among all people, particularly health care workers #nCoV
3:40pm · 12 May 13

From September 2012 to date, WHO has been informed of a total of 34 novel coronavirus laboratory-confirmed cases, incl. 18 deaths. #nCoV
5:14pm · 12 May 13


RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
Citaat
Novel coronavirus infection - update  
The Ministry of Social Affairs and Health in France has informed WHO of an additional laboratory-confirmed case with infection of the novel coronavirus (NCoV).

This patient was identified as part of the epidemiological investigation initiated by the French authorities, following laboratory confirmation of the first case on 7 May 2013. The patient shared a hospital room in Valenciennes with the first laboratory-confirmed patient from 27 to 29 April 2013. The patient is currently hospitalized and isolated in an infectious disease hospital.

Among 120 persons identified as contacts of the first laboratory-confirmed case in France, laboratory tests were conducted by Pasteur Institute in Paris on five suspected cases, of which four tested negative, one (mentioned above) tested positive.

In Saudi Arabia, an investigation is ongoing into an outbreak in a health care facility, where 15 patients, including seven deaths have been confirmed.

From September 2012 to date, WHO has been informed of a global total of 34 laboratory confirmed cases of human infection with nCoV, including 18 deaths.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.

Health care providers are advised to be vigilant among recent travelers returning from areas affected by the virus who develop severe SARI. Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that nCoV infection should be considered even with atypical signs and symptoms in patients who are significantly immune compromised.

All Member States are reminded to promptly assess and notify WHO of any new case of infection with nCoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course.

WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.

WHO continues to closely monitor the situation.
bron: WHO


RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
Citaat
Novel coronavirus infection - update

15 May 2013 - The Ministry of Health in Saudi Arabia has informed WHO of an additional two laboratory-confirmed cases with infection of the novel coronavirus (nCoV).

The two patients are health care workers who were exposed to patients with confirmed nCoV. The first patient is a 45-year-old man who became ill on 2 May 2013 and is currently in a critical condition. The second patient is a 43-year-old woman with a coexisting health condition, who became ill on 8 May 2013 and is in a stable condition.

Although health care associated transmission has been observed before with nCoV (in Jordan in April 2012), this is the first time health care workers have been diagnosed with nCoV infection after exposure to patients. Health care facilities that provide care for patients with suspected nCoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients and health care workers. Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC).

Since the beginning of May 2013 to date, a total of 21 patients, including nine deaths, have been reported from the outbreak primarily linked to a health care facility in the Eastern part of Saudi Arabia. The government is conducting ongoing investigation into the outbreak.

From September 2012 to date, WHO has been informed of a global total of 40 laboratory confirmed cases of human infection with nCoV, including 20 deaths from 6 countries (France, Germany, Jordan, Qatar, Saudi Arabia, United Kingdom).

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.

Health care providers are advised to be vigilant among recent travelers returning from areas affected by the virus who develop severe SARI. Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that nCoV infection should be considered even with atypical signs and symptoms in patients who are significantly immune compromised.

All Member States are reminded to promptly assess and notify WHO of any new case of infection with nCoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course.

WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.

WHO continues to closely monitor the situation.
bron: WHO


oma

  • Senior gebruiker
  • ****
  • Berichten: 10,711
Citaat
23 MAY 2013 - The Ministry of Health in Saudi Arabia has notified WHO of an additional laboratory-confirmed case of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV).

The fatal case was reported from Al-Qaseem region in the Central part of the country and is not related to the cluster of cases reported from Al-Ahsa region in the Eastern part of the country. The patient was a 63-year-old man with an underlying medical condition who was admitted to a hospital with acute respiratory distress on 15 May 2013 and died on 20 May 2013. Investigation into contacts of this case is ongoing.

The Saudi authorities are also continuing the investigation into the outbreak that began in a health care facility since the beginning of April 2013 in Al-Ahsa. To date, a total of 22 patients including 10 deaths have been reported from the outbreak.

Globally, from September 2012 to date, WHO has been informed of a total of 44 laboratory-confirmed cases of infection with MERS-CoV, including 22 deaths.

WHO has received reports of laboratory-confirmed cases from the following countries in the Middle East: Jordan, Qatar, Saudi Arabia, and the United Arab Emirates (UAE). France, Germany, Tunisia and the United Kingdom also reported laboratory-confirmed cases; they were either transferred for care of the disease or returned from Middle East and subsequently became ill. In France, Tunisia and the United Kingdom, there has been limited local transmission among close contacts who had not been to the Middle East but had been in close contact with the laboratory-confirmed or probable cases.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.

Health care providers are advised to maintain vigilance. Recent travellers returning from the Middle East who develop SARI should be tested for MERS-CoV as advised in the current surveillance recommendations. Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that MERS-CoV infection should be considered even with atypical signs and symptoms, such as diarrhoea, in patients who are immunocompromised.

Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC). Health care facilities that provide care for patients suspected or confirmed with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients, health care workers and visitors.

All Member States are reminded to promptly assess and notify WHO of any new case of infection with MERS-CoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course. Investigation into the source of exposure should promptly be initiated to identify the mode of exposure, so that further transmission of the virus can be prevented.

WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.

WHO continues to closely monitor the situation.

Note: To provide uniformity and facilitate communication about the disease, the Coronavirus Study Group of the International Committee on Taxonomy of Viruses has decided to call the new virus Middle East respiratory syndrome coronavirus (MERS-CoV). Reference: De Groot RJ, et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J Virol. Published ahead of print 15 May 2013. doi:10.1128/JVI.01244-13.


RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
Citaat
Nieuw SARS-virus is 'gevaar voor hele wereld'
Het nieuwe SARS-virus dat al aan meer dan 20 mensen het leven heeft gekost, is een gevaar voor de hele wereld. Daarvoor heeft de Wereldgezondheidsorganisatie (WHO) dinsdag gewaarschuwd. WHO-directeur Margaret Chan zegt zich "grote zorgen" te maken over het virus, dat Middle East Respiratory Virus (MERS) is genoemd. lees verder
bron: Skipr


RAdeR

  • Hoofd Rode Kruis Noodhulpteam, BLS instructeur
  • Senior gebruiker
  • ****
  • Berichten: 14,616
Citaat
Saudi Arabia says MERS treatment delayed
A Dutch university is accused of slowing down the development of a vaccine for a deadly respiratory virus.
Saudi Arabia has accused a laboratory in the Netherlands of slowing down the development of a treatment for the MERS coronavirus that has so far killed 38 people.
The respiratory virus, which originated in the Middle East, spreads easily between people and appears more deadly than SARS according to doctors.
Saudi Arabia has said on Thursday that last year virologist Dr Ali Mohamad Zaki sent a sample of the virus to the Netherlands' Erasmus University. lees verder

bron: Aljazeera


oma

  • Senior gebruiker
  • ****
  • Berichten: 10,711
Reactie #8 Gepost op: 26 juni 2013, 12:52:38
Citaat
ABU DHABI // A strain of the Sars-like virus that killed an Emirati man has origins in the UAE and Qatar, a report has revealed.


Read more: http://www.thenational.ae/news/uae-news/health/killer-coronavirus-experts-link-deadly-mers-disease-to-uae-and-qatar#ixzz2XJmyuVIO
Follow us: @TheNationalUAE on Twitter | thenational.ae on Facebook


oma

  • Senior gebruiker
  • ****
  • Berichten: 10,711
Reactie #9 Gepost op: 26 juni 2013, 12:53:54
Citaat
The Ministry of Public Health is on high alert for possible symptoms of the deadly Middle East respiratory syndrome coronavirus (MERS) which has killed 38 people worldwide.

http://www.pattayamail.com/news/health-ministry-on-high-alert-for-new-coronavirus-27550